Internationalization of Traditional/Complementary Medicine products: Market entry as medicine

Chinese Medicine (United Kingdom)

Volumn 13, Issue 1, 2018, Pages

  Li, Jiatong ^a   Zhu, Jianfan ^a   Hu, Hao ^a   Harnett, Joanna E ^b   Lei, Chi Ieong ^c   Chau, Ka Yin ^d   Chan, Ging ^a   Ung, Carolina Oi Lam ^a,b,c  

^a University of Macau   (Macao)

^b University of Sydney   (Australia)

^c Pharmaceutical Society of Macau   (Macao)

^d CITY UNIVERSITY OF MACAU   (Macao)

Author keywords

Chinese patent medicines; Efficacy; Internationalization; Proprietary Chinese medicines; Quality; Registration; Safety; Traditional and Complementary Medicine; Traditional Chinese medicines

Indexed keywords

ALTERNATIVE MEDICINE; AUSTRALIA; CANADA; CHINESE MEDICINE; CONSUMER; DRUG EFFICACY; DRUG SAFETY; GOOD MANUFACTURING PRACTICE; HONG KONG; HUMAN; MACAO; MARKET; PATENT; REGISTRATION; REVIEW; RISK ASSESSMENT; SINGAPORE; STANDARD;

EID: 85054767048     PISSN: None     EISSN: 17498546     Source Type: Journal    
DOI: 10.1186/s13020-018-0209-6     Document Type: Review

References (43)

1. Zhong F. The current development status and prospect on Chinese medicine health foods. China Health Ind. 2014;11(10):187-8.
2. Nirali J, Shankar M. Global market analysis of herbal drug formulations. Int J Ayu Pharm Chem. 2016;4(1):59-65.
3. World Health Organization. Legal status of traditional medicine and complementary/alternative medicine: a worldwide review. 2001. http://apps.who.int/medicinedocs/pdf/h2943e/h2943e.pdf. Accessed 28 Jan 2018.
4. World Health Organization. WHO Traditional Medicine Strategy 2014-2023. 2013. http://apps.who.int/iris/bitstream/10665/92455/3/9789245506096-chi.pdf?ua=1. Accessed 28 Jan 2018.
5. Lin AX, Chan G, Hu Y, Ouyang D, Ung CO, Shi L, Hu H. Internationalization of traditional Chinese medicine: Current international market, internationalization challenges and prospective suggestions. Chin Med. 2018;13(1):9. https://doi.org/10.1186/s13020-018-0167-z.
6. The State Council, The People's Republic of China, The Health Care Plan in the 13th Five-Year Plan. 2017. http://www.gov.cn/zhengce/content/2017-01/10/content-5158488.htm. Assessed 16 Sept 2018.
7. Wu G. International opportunities and challenges of Chinese medicine. Co-op Econ Sci. 2015;11:83-4.
8. Wu WY, Hou JJ, Long HL, Yang WZ, Liang J, Guo DA. TCM-based new drug discovery and development in China. Chin J Nat Med. 2014;12(4):0241-50.
9. Jiang M, Yang J, Zhang C, Liu B, Chan K, Cao H, Lu A. Clinical studies with traditional Chinese medicine in the past decade and future research and development. Planta Med. 2010;76(17):2048-64.
10. Zhang H, Wang N, Zheng L. The influence of acceding to WTO on progress of modernization of Chinese materia medica in the 21st century. China Pharm. 2000;11(2):51-3.
11. Zhang L. Discuss on the export barriers and countermeasures of traditional Chinese medicine. Chin Bus Trade. 2011;7:204-5.
12. Alostad A, Steinke D, Schafheutle E. International comparison of five herbal medicine registration systems to inform regulation development: United Kingdom, Germany, United States of America, United Arab Emirates and Kingdom of Bahrain. Pharmaceut Med. 2018;32(1):39-49.
13. World Health Organization. Traditional, complementary and integrative medicine. 2018. http://www.who.int/traditional-complementary-integrative-medicine/about/en. Accessed 16 Sept 2018.
14. World Health Organization. National policy on traditional medicine and regulation of herbal medicines - report of a WHO Global Survey. 2005. http://apps.who.int/medicinedocs/en/d/Js7916e/. Accessed 16 Sept 2018.
15. Health Bureau, The Government of the Macau SAR. 2018. http://www.ssm.gov.mo. Accessed 16 Sept 2018.
16. Chinese Medicine Council of Hong Kong SAR Government. 2018. http://www.cmchk.org.hk/. Accessed 16 Sept 2018.
17. Chinese Medicine Division, Department of Health, The Government of the Hong Kong SAR. 2018. http://www.cmd.gov.hk/html/eng/index.html. Accessed 16 Sept 2018.
18. Health Sciences Authority of Singapore. 2018. http://www.hsa.gov.sg. Accessed 16 Sept 2018.
19. Therapeutic Goods Administration of Australia. 2018. http://www.tga.gov.au. Accessed 16 Sept 2018.
20. Health Canada. https://www.canada.ca/en/health-canada/services/drugs-health-products/natural-non-prescription.html. Accessed 16 Sept 2018.
21. European Medicines Agency. http://www.ema.europa.eu/ema/. Accessed 16 Sept 2018.
22. Medicines Evaluation Board of the Netherlands. 2018. https://english.cbg-meb.nl/. Accessed 16 Sept 2018.
23. Medicines and Healthcare Products Regulation Agency of the UK. 2018. https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency. Accessed 16 Sept 2018.
24. US Food and Drug Administration. https://www.fda.gov/AboutFDA/default.htm. Accessed 16 Sept 2018.
25. Hong Kong e-Legislation. The Government of Hong Kong SAR Government. Chinese Medicine Ordinance 1999. 1999. https://www.elegislation.gov.hk/hk/cap549. Accessed 16 Sept 2018.
26. Chinese Medicine Council of The Government of Hong Kong SAR. Registration of proprietary Chinese Medicines Application Handbook. 2018. http://www.cmchk.org.hk/pcm/pdf/reg-handbook-e.pdf. Accessed 16 Sept 2018.
27. Graham D. Regulation of proprietary traditional Chinese medicines in Australia. Chin J Nat Med. 2017;15(1):12-4.
28. Therapeutic Goods Administration of Australia. Therapeutic Goods Administration Annual Performance Statistics Report July 2016 to June 2017. 2017. https://www.tga.gov.au/sites/default/files/annual-performance-statistics-report-july-2016-june-2017.pdf. Accessed 16 Sept 2018.
29. Therapeutic Goods Administration of Australia. Consultation: reforms to the regulatory framework for complementary medicines. 2017. https://www.tga.gov.au/sites/default/files/consultation-reforms-regulatory-framework-complementary-medicines-assessment-pathways.pdf. Accessed 16 Sept 2018.
30. European Medicines Agency. Human regulatory - herbal medicinal products. 2018. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general-content-000208.jsp. Accessed 16 Sept 2018.
31. European Medicines Agency. Herbal products - multidisciplinary: herbal medicinal products. 2018. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general-content-000497.jsp&mid=WC0b01ac0580033a9b. Accessed 16 Sept 2018.
32. Kroes B. The legal framework governing the quality of (traditional) herbal medicinal products in the European Union. Eur J Integr Med. 2014;6(6):701.
33. van Galen E. Traditional herbal medicines worldwide, from reappraisal to assessment in Europe. J Ethnopharmacol. 2014;158:498-502.
34. Cranz H, Anquez-Traxler C. TradReg 2013: regulation of herbal and traditional medicinal products - European and global strategies - international symposium. J Ethnopharmacol. 2014;158:495-7.
35. Wiesener S, Falkenberg T, Hegyi G, Hök J, di Sarsina PR, Fønnebø V. Legal status and regulation of complementary and alternative medicine in Europe. Forsch Komplementmed. 2012;19(Suppl. 2):29-36.
36. Medicine Evaluation Board, The Netherlands. Diao Xin Xue Kang, capsules for oral use SU BioMedicine B.V., The Netherlands. 2012. https://db.cbg-meb.nl/Pars/h102142.pdf. Accessed 16 Sept 2018.
37. Tasly Phar. International Co., Ltd. Tasly Danshen Capsule was certified by CBG-MEB as a herbal drug. 2016. https://www.taslyint.com/show-86-506-1.html. Accessed 16 Sept 2018.
38. US Food and Drug Administration. Guidance for industry: botanical drug development. https://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM458484.pdf. Accessed 16 Sept 2018.
39. Fan TP, Deal G, Koo HL, et al. Future development of global regulations of Chinese herbal products. J Ethnopharmacol. 2012;140:568-86.
40. Wiesner J, Knöss W. Future visions for traditional and herbal medicinal products - a global practice for evaluation and regulation? J Ethnopharmacol. 2014;158:516-8.
41. Shen J, Wang K, Hu Q, Su J, Zhang W. Establishment quality control method of traditional Chinese medicine based on efficacy and safety. Modernization Trad Chin Med Materia Med. 2014;3:502-5.
42. Fleischer T, Su Y, Lin S. How do government regulations influence the ability to practice Chinese herbal medicine in western countries. J Ethnopharmacol. 2017;196:104-9.
43. Ajazuddin SS. Legal regulations of complementary and alternative medicines in different countries. Pharmacogn Rev. 2012;6(12):154.